Wygant Jonathan's Form 4 filing
Veracyte, Inc. (VCYT) · filed Nov 29, 2024
- Accession no.
- 0001384101-24-000170
- Filed
- Nov 29, 2024
- Trade date
- Nov 27, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $215.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wygant JonathanCIK 0001584145 | Officer (VP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | Common Stock | SSaleDisposed | −5,032 | $42.89F1 | −$215,822.48 | 42,313 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents weighted average sales price. Sale prices for the transactions range from $42.8028 to $42.9001. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.